Skip to main content

Press & Media

Press & Media

New Data Validating the First AI-Based Biomarker to Stratify Risk of Metastasis in Radical Prostatectomy Patients with Biochemical Recurrence

ArteraAI, the developer of multimodal artificial intelligence-based prognostic and predictive cancer tests, announced the val [...]

Read more

Press & Media

Doctors Explain What Prostate Cancer Screenings Involve

If you've never had a prostate cancer screening, you may worry that it will be embarrassing and uncomfortable. Doctors say th [...]

Read more

Press & Media

ArteraAI and Movember Announce New Relationship

ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, today anno [...]

Read more

Press & Media

ArteraAI Prostate Test Included in NCCN Guidelines

The National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Prostate Cancer have included the ArteraAI [...]

Read more

Press & Media

ArteraAI Included in the 2024 NCCN Guidelines® for Prostate Cancer

ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announced [...]

Read more

Press & Media

Here’s how AI will drive health care to meet consumer expectations

The rapid transformation of the health care landscape is undeniable. It is marked not only by groundbreaking technologies and [...]

Read more

Press & Media

Exclusive: ArteraAI nabs $20M to take personalized cancer care global

ArteraAI, a developer of AI tests to personalize therapy for cancer patients, raised $20 million in additional funding, CEO A [...]

Read more

Press & Media

ArteraAI Secures $20 Million in Funding to Further Personalize Cancer Therapy With Multimodal AI

ArteraAI, the developer of multimodal artificial intelligence (MMAI) based predictive and prognostic cancer tests, announced [...]

Read more

Press & Media

Prostate cancer myths and common misconceptions from an oncologist amid high-profile cases

Amid a flurry of high-profile prostate cancer announcements, doctors are weighing in to debunk common myths about the disease [...]

Read more

1 2 3 5